These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29621747)

  • 1. Changes in Biomarker Profile and Left Ventricular Hypertrophy Regression: Results from the Frequent Hemodialysis Network Trials.
    Chan CT; Kaysen GA; Beck GJ; Li M; Lo J; Rocco MV; Kliger AS;
    Am J Nephrol; 2018; 47(3):208-217. PubMed ID: 29621747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of frequent hemodialysis on matrix metalloproteinases, their tissue inhibitors, and FGF23: Implications for blood pressure and left ventricular mass modification in the Frequent Hemodialysis Network trials.
    Chan CT; Kaysen GA; Beck GJ; Li M; Lo JC; Rocco MV; Kliger AS;
    Hemodial Int; 2020 Apr; 24(2):162-174. PubMed ID: 31826326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Predialysis Serum Sodium Level Modifies the Effect of Hemodialysis Frequency on Left-Ventricular Mass: The Frequent Hemodialysis Network Trials.
    Raimann JG; Chan CT; Daugirdas JT; Depner T; Greene T; Kaysen GA; Kliger AS; Kotanko P; Larive B; Beck G; Lindsay RM; Rocco MV; Chertow GM; Levin NW;
    Kidney Blood Press Res; 2021; 46(6):768-776. PubMed ID: 34644706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials.
    Chan CT; Greene T; Chertow GM; Kliger AS; Stokes JB; Beck GJ; Daugirdas JT; Kotanko P; Larive B; Levin NW; Mehta RL; Rocco M; Sanz J; Schiller BM; Yang PC; Rajagopalan S;
    Circ Cardiovasc Imaging; 2012 Mar; 5(2):251-61. PubMed ID: 22360996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of etelcalcetide on cardiac hypertrophy in hemodialysis patients: a randomized controlled trial (ETECAR-HD).
    Dörr K; Kammer M; Reindl-Schwaighofer R; Lorenz M; Loewe C; Marculescu R; Erben R; Oberbauer R
    Trials; 2019 Oct; 20(1):601. PubMed ID: 31651370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of left ventricular mass and hypertrophy in hemodialysis patients assessed by cardiac magnetic resonance imaging.
    Patel RK; Oliver S; Mark PB; Powell JR; McQuarrie EP; Traynor JP; Dargie HJ; Jardine AG
    Clin J Am Soc Nephrol; 2009 Sep; 4(9):1477-1483. PubMed ID: 19713289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling.
    Cataliotti A; Malatino LS; Jougasaki M; Zoccali C; Castellino P; Giacone G; Bellanuova I; Tripepi R; Seminara G; Parlongo S; Stancanelli B; Bonanno G; Fatuzzo P; Rapisarda F; Belluardo P; Signorelli SS; Heublein DM; Lainchbury JG; Leskinen HK; Bailey KR; Redfield MM; Burnett JC
    Mayo Clin Proc; 2001 Nov; 76(11):1111-9. PubMed ID: 11702899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of short daily hemodialysis and extended standard hemodialysis on blood pressure and cardiac hypertrophy: a comparative study.
    Fagugli RM; Pasini P; Pasticci F; Ciao G; Cicconi B; Buoncristiani U
    J Nephrol; 2006; 19(1):77-83. PubMed ID: 16523430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levocarnitine Improves Cardiac Function in Hemodialysis Patients With Left Ventricular Hypertrophy: A Randomized Controlled Trial.
    Higuchi T; Abe M; Yamazaki T; Okawa E; Ando H; Hotta S; Oikawa O; Kikuchi F; Okada K; Soma M
    Am J Kidney Dis; 2016 Feb; 67(2):260-70. PubMed ID: 26508680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular mass relates to average systolic blood pressure, but not loss of circadian blood pressure in stable hemodialysis patients: an ambulatory 48-hour blood pressure study.
    Nishikimi T; Minami J; Tamano K; Takahashi M; Numabe A; Futoo Y; Honda T; Kobayashi T; Uetake S; Mori Y; Saito T; Matsuoka H
    Hypertens Res; 2001 Sep; 24(5):507-14. PubMed ID: 11675944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease.
    McCullough PA; Chan CT; Weinhandl ED; Burkart JM; Bakris GL
    Am J Kidney Dis; 2016 Nov; 68(5S1):S5-S14. PubMed ID: 27772643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of left ventricular hypertrophy with high-sensitive C-reactive protein in hemodialysis patients.
    Monfared A; Salari A; Kazemnezhad E; Lebadi M; Khosravi M; Mehrjardi NK; Rahimifar S; Amini N
    Int Urol Nephrol; 2013 Dec; 45(6):1679-86. PubMed ID: 23306861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between hippuric acid and left ventricular hypertrophy in maintenance hemodialysis patients.
    Yu TH; Tang WH; Lu YC; Wang CP; Hung WC; Wu CC; Tsai IT; Chung FM; Houng JY; Lan WC; Lee YJ
    Clin Chim Acta; 2018 Sep; 484():47-51. PubMed ID: 29758204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood pressures values during evaluation of 24-h ambulatory blood pressure monitoring and left ventricular hypertrophy in patients with chronic renal failure treated with hemodialysis (HD)].
    Wanic-Kossowska M; Leman P; Kobelski M; Czekalski S
    Pol Arch Med Wewn; 2002 Jan; 107(1):29-35. PubMed ID: 12046341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of change in volume and left-ventricular hypertrophy on left-ventricular mechanical dyssynchrony in children with end-stage renal disease.
    Kobayashi D; Patel SR; Mattoo TK; Valentini RP; Aggarwal S
    Pediatr Cardiol; 2012 Oct; 33(7):1124-30. PubMed ID: 22441563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inadequate diagnosis and therapy of arterial hypertension as causes of left ventricular hypertrophy in uremic dialysis patients.
    Cannella G; Paoletti E; Ravera G; Cassottana P; Araghi P; Mulas D; Peloso G; Delfino R; Messa P
    Kidney Int; 2000 Jul; 58(1):260-8. PubMed ID: 10886571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between hypervolemia, left ventricular hypertrophy and fibroblast growth factor 23 in hemodialysis patients.
    Unver S; Kavlak E; Gümüsel HK; Celikbilek F; Esertas K; Muftuoglu T; Kirilmaz A
    Ren Fail; 2015 Jul; 37(6):951-6. PubMed ID: 26030798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diastolic dysfunction in asymptomatic hemodialysis patients in the light of the current echocardiographic guidelines.
    Malik J; Kudlicka J; Valerianova A; Kovarova L; Kmentova T; Lachmanova J
    Int J Cardiovasc Imaging; 2019 Feb; 35(2):313-317. PubMed ID: 30815807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of secondary hyperparathyroidism in left ventricular hypertrophy of patients under chronic hemodialysis.
    Randon RB; Rohde LE; Comerlato L; Ribeiro JP; Manfro RC
    Braz J Med Biol Res; 2005 Sep; 38(9):1409-16. PubMed ID: 16138225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Left ventricular hypertrophy in patients with chronic renal failure treated by hemodialysis].
    Wanic-Kossowska M; Lehmann P; Czekalski S
    Pol Arch Med Wewn; 2002 Jun; 107(6):539-46. PubMed ID: 12375575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.